Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 5/20 | 0.44 |
| ▸ | HTR1A | P08908 | 4/20 | 0.44 |
| ▸ | HTR1B | P28222 | 4/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | HTR7 | P34969 | 1/20 | 0.38 |
| ▸ | HTR6 | P50406 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.36 |
| ▸ | DRD2 | P14416 | 4/20 | 0.36 |
| ▸ | DRD3 | P35462 | 4/20 | 0.36 |
| ▸ | DRD4 | P21917 | 3/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CXCR2 | P25025 | 1/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13070399 | 0.97 | HTR1D (0.44) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL16108092 | 0.95 | HTR1A (0.43) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL10023272 | 0.91 | HTR1D (0.47) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL1702438 | 0.91 | HTR1D (0.47) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL2810467 | 0.91 | HTR1D (0.47) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL29511664 | 0.91 | HTR1D (0.47) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL17548705 | 0.91 | HTR1D (0.47) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL717994 | 0.90 | HTR1D (0.44) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL18133363 | 0.87 | HTR1A (0.44) | HTR1DHTR1AHTR1BCA1CA2 | |
| SCHEMBL12465666 | 0.84 | HPRT1 (0.44) | HTR1DHTR1AHTR1BCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11600790-B2 | Polycyclic aromatic compound for organic electroluminescent device | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2023-03-07 | — | — | US | disclosed |
| US-20210167288-A1 | POLYCYCLIC AROMATIC COMPOUND | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2021-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210167288-A1 | POLYCYCLIC AROMATIC COMPOUND | ARNT, TYR, AHR | HTR1D 4146/4885HTR1A 3489/4885HTR1B 3709/4885 |
| US-11600790-B2 | Polycyclic aromatic compound for organic electroluminescent device | AOC2, TYR, BMI1 | HTR1D 4351/4885HTR1A 4066/4885HTR1B 4224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.